IMATINIB MAINTENANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

被引:0
|
作者
Kebriaei, P. [1 ]
Chiattone, A. [1 ]
Saliba, R. [1 ]
Jones, D. [1 ]
Anderlini, P. [1 ]
Andersson, B. [1 ]
Khouri, I [1 ]
Worth, L. [1 ]
Ravandi, F. [1 ]
Thomas, D. [1 ]
Kantarjian, H. [1 ]
Hamerschlak, N. [2 ]
Rodrigues, M. [2 ]
de Lima, M. [1 ]
Giralt, S. [1 ]
Champlin, R. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Albert Einstein Israeli Hosp HIAE, Sao Paulo, Brazil
关键词
D O I
10.1016/j.bbmt.2009.12.232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
195
引用
收藏
页码:S230 / S230
页数:1
相关论文
共 50 条
  • [21] Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era
    Chen, Huan
    Liu, Kai-yan
    Xu, Lan-ping
    Chen, Yu-hong
    Zhang, Xiao-hui
    Wang, Yu
    Qin, Ya-zhen
    Liu, Yan-rong
    Lai, Yue-yun
    Huang, Xiao-jun
    LEUKEMIA RESEARCH, 2017, 59 : 136 - 141
  • [22] Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL)
    Wassmann, B
    Pfeifer, H
    Scheuring, U
    Klein, SA
    Gökbuget, N
    Binckebanck, A
    Martin, H
    Gschaidmeier, H
    Hoelzer, D
    Ottmann, OG
    LEUKEMIA, 2002, 16 (12) : 2358 - 2365
  • [23] Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate
    Ribera, JM
    Oriol, A
    Gonzalez, M
    Vidriales, MB
    Xicoy, B
    Grau, J
    Esteve, J
    Brunet, S
    Del Potro, E
    Moreno, MJ
    Tormo, M
    Martin-Reina, MV
    Deben, G
    Parody, R
    Lahuerta, UJ
    San Miguel, JF
    BLOOD, 2004, 104 (11) : 203B - 204B
  • [24] Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Mizuta, Shuichi
    Yanada, Masamitsu
    Sugiura, Isamu
    Yagasaki, Fumiharu
    Yujiri, Toshiaki
    Takeuchi, Makoto
    Hatta, Yoshihiro
    Kimura, Yukihiko
    Ueda, Yasunori
    Kanamori, Heiwa
    Usui, Noriko
    Akiyama, Hideki
    Miyazaki, Yasushi
    Ohtake, Shigeki
    Jinnai, Itsuro
    Matsuo, Keitaro
    Naoe, Tomoki
    Ohno, Ryuzo
    BLOOD, 2008, 112 (11) : 176 - 177
  • [25] Clinical Outcome of Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL): Experience From a Single Institution
    Doki, Noriko
    Ohashi, Kazuteru
    Oshikawa, Gaku
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (01) : 61 - 66
  • [26] Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)
    Umakanthan, Jayadev Manikkam
    Chen, Baojiang
    Gundabolu, Krishna
    Bhatt, Vijaya R.
    BLOOD, 2017, 130
  • [27] Challenges of Maintenance Tyrosine Kinase Inhibitor Therapy after Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Othman, Tamer
    Koller, Paul B.
    Tsai, Ni-Chun
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Otoukesh, Salman
    Amanam, Idoroenyi
    Ngo, Dat
    Chen, Jason
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Arslan, Shukaib
    Ball, Brian J.
    Stewart, Forrest M.
    Curtin, Peter T.
    Artz, Andrew S.
    Snyder, David S.
    Marcucci, Guido
    Forman, Stephen J.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Pullarkat, Vinod A.
    Aldoss, Ibrahim
    Mei, Matthew
    BLOOD, 2022, 140 : 4821 - 4822
  • [28] Allogeneic hematopoietic stem cell transplantation after combination therapy with imatinib and intensive chemotherapy for newly diagnosed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia.
    Usui, N
    Yano, S
    Takahara, S
    Asai, O
    Dobashi, N
    Osawa, H
    Takei, Y
    Ogasawara, Y
    Otubo, H
    Yamaguchi, Y
    Saito, T
    Minami, J
    Kaito, K
    Kobayashi, M
    BLOOD, 2005, 106 (11) : 410B - 411B
  • [29] Allogeneic myeloablative hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
    Yanada, M
    Naoe, T
    Lida, H
    Atsuta, Y
    Yamamoto, K
    Tanaka, J
    Takahashi, S
    BLOOD, 2005, 106 (11) : 330A - 330A
  • [30] Outcomes Post-Allogeneic Hematopoietic Cell Transplantation Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Othman, Tamer
    Aldoss, Ibrahim
    Tsai, Ni-Chun
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Otoukesh, Salman
    Amanam, Idoroenyi
    Ngo, Dat
    Chen, Jason
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Arslan, Shukaib
    Ball, Brian J.
    Stewart, Forrest M.
    Curtin, Peter T.
    Artz, Andrew S.
    Snyder, David S.
    Marcucci, Guido
    Forman, Stephen J.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Pullarkat, Vinod A.
    Mei, Matthew
    Koller, Paul B.
    BLOOD, 2022, 140 : 10568 - 10570